Why One Peptide Has Five Names: Nomenclature in Research Supply

Why One Peptide Has Five Names: Nomenclature in Research Supply

A researcher cross-referencing peptide suppliers quickly discovers that the same compound may appear under four or five different names, none of them obviously related. This is not carelessness on the part of suppliers. It reflects several parallel naming conventions that developed independently and remain in simultaneous use. Understanding them makes identification reliable rather than guesswork.

This article covers naming and identification only. No use of any material is described.

Trivial names

Most research peptides are known primarily by a trivial name — a short coined label with no systematic meaning. Ipamorelin, Semax, Selank, Epitalon and Tesamorelin are all trivial names. They are convenient and near-universally used, but they carry no structural information whatsoever. Nothing about the word “Selank” tells you it is a seven-residue peptide.

Development codes

Compounds that passed through a formal development programme often carry an alphanumeric code from that programme, which persists in the literature indefinitely. Tesamorelin is also catalogued as TH9507. These codes frequently predate the trivial name and may be the dominant identifier in older publications, which is why a literature search on the trivial name alone can miss substantial prior work.

Fragment and modification notation

Where a peptide corresponds to part of a larger parent sequence, notation exists to express exactly which part. GRF(1-29) denotes residues one to twenty-nine of growth hormone-releasing factor. ACTH(4-7) denotes residues four to seven of adrenocorticotropic hormone. This notation is precise and informative — considerably more so than any trivial name.

Modifications are layered on top. A prefix such as N-acetyl indicates an acetyl group at the N-terminus. PEG- indicates polyethylene glycol conjugation. Mod- simply indicates modification, which is honest but uninformative, as in Mod GRF 1-29. Descriptions like “with DAC” and “without DAC” specify the presence or absence of a conjugated component.

This layering is how a single compound accumulates names. CJC-1295 without DAC and Mod GRF 1-29 are the same molecule described through two different conventions — one via development code plus a statement of what it lacks, the other via fragment notation plus a statement that it is modified.

Sequence notation

The sequence itself functions as a name, written in either three-letter or single-letter amino acid code. Ala-Glu-Asp-Gly and AEDG denote the same tetrapeptide. Both are entirely unambiguous as to composition and order, though neither indicates modifications, stereochemistry or terminal groups unless additional notation is added.

For short peptides the sequence is often used as the working name directly — Pinealon is routinely catalogued as EDR.

Salt forms

A peptide is frequently supplied not as the free base but as a salt, most commonly an acetate or trifluoroacetate, arising from the purification process. Where this is specified the name reflects it, as in Oxytocin Acetate.

This is not a naming quirk to be ignored. The salt form contributes to the total mass of material in a vial, so the peptide content of a stated quantity differs between salt forms. It also affects solubility characteristics and can influence analytical behaviour.

Identifying compounds reliably

Given all this, name matching is a poor identification method. Three checks are far more dependable, and should agree with one another.

• CAS registry number — a unique identifier assigned to a specific chemical substance. If two catalogue entries share a CAS number they are the same substance; if they differ, they are not.
• Molecular formula — directly reflects atomic composition, and will differ between any two genuinely distinct compounds.
• Molecular weight — useful, but the weakest of the three on its own. Sermorelin and CJC-1295 without DAC differ by roughly 10 g/mol despite being different compounds, so mass alone can mislead.

Where a supplier publishes CAS number, molecular formula, molecular weight and sequence together, cross-referencing becomes straightforward regardless of what name appears at the top of the page. Where only a trivial name is given, identification is genuinely uncertain.

Worked examples

Three cases from a typical catalogue illustrate how the conventions stack.

• Tesamorelin — trivial name Tesamorelin, development code TH9507, descriptive form “growth hormone-releasing factor analogue”, CAS 218949-48-5. Four ways of referring to one compound, only one of which is unambiguous.
• CJC-1295 without DAC — also Mod GRF 1-29, CAS 863288-34-0, approximately 3,367.0 g/mol. Here two names describe the same molecule through different conventions, one by development code and absence of a component, the other by fragment notation and a modification marker.
• Pinealon — also EDR, also Glu-Asp-Arg, CAS 175175-23-2. Trivial name plus two forms of sequence notation.

In each case the CAS number resolves the ambiguity immediately, and in each case the names alone would not.

Where names mislead

Two failure modes recur often enough to be worth naming explicitly.

The first is the assumption that similar names indicate similar compounds. CJC-1295 with DAC and CJC-1295 without DAC differ by roughly 280 g/mol and are separate chemical entities; the shared name element is genuinely misleading about how closely related they are in analytical terms.

The second is the assumption that different names indicate different compounds. A researcher comparing a Mod GRF 1-29 listing against a CJC-1295 without DAC listing may reasonably conclude they are looking at two products when they are looking at one. Both errors are avoided by the same discipline: check the identifiers, not the label.

Corix Labs publishes CAS number, molecular formula, molecular weight and sequence in the specification table of each catalogue entry, alongside analytical documentation at batch level.

Corix Labs publishes analytical documentation for its research materials. See third-party testing reports for further detail on how batches are verified.

All materials referenced in this article are supplied strictly for laboratory research and analytical use. They are not licensed medicines and are not sold for use in humans or animals. Nothing in this article constitutes guidance on administration, preparation for use, or any clinical, therapeutic, diagnostic or cosmetic application.